Last reviewed · How we verify
NCT07565441
Drug-Drug Interactions of JMKX003142 in Healthy Participants
Phase 1 trial testing JMKX003142 tablets in ADPKD (Autosomal Dominant Polycystic Kidney Disease) in 112 participants. Not yet recruiting.
Quick facts
| Lead sponsor | Jemincare |
|---|---|
| Phase | Phase 1 |
| Status | Not yet recruiting |
| Enrollment | 112 |
| Start date | 11 May 2026 |
| Estimated completion | 28 February 2027 |
Drugs / interventions tested
- JMKX003142 tablets — full drug profile →
- Fluconazole Capsules — full drug profile →
- Cocktail Substrates (Midazolam Oral Solution, Rosuvastatin Calcium Tablets, and Digoxin Tablets)
- Cyclosporine Soft Capsules
- Omeprazole Enteric-coated Tablets
- Efavirenz Tablets
- JMKX003142 tablets — full drug profile →
- JMKX003142 tablets — full drug profile →
- JMKX003142 tablets — full drug profile →
Conditions studied
- ADPKD (Autosomal Dominant Polycystic Kidney Disease) — all drugs for ADPKD (Autosomal Dominant Polycystic Kidney Disease) →
Sponsor
Jemincare — full company profile →
Who can join
Eligibility, any sex, with ADPKD (Autosomal Dominant Polycystic Kidney Disease).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07565441
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of JMKX003142 tablets
Trials testing the same drug.
- NCT07470177 — A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults · Phase 1 · not yet recruiting
- NCT07463053 — Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers · Phase 1 · not yet recruiting
- NCT06670534 — A Dose-finding Study of JMKX003142 in Treatment of Renal Edema · Phase 2 · recruiting
Other recruiting trials for ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Currently open trials in the same condition.
- NCT06800651 — Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) · Phase 2 · recruiting
Other Jemincare trials
Trials by the same sponsor.
- NCT07513857 — Trial of JYB1904 Injection in Adolescent Participants · Phase 1 · not yet recruiting
- NCT07402213 — Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria. · Phase 3 · not yet recruiting
- NCT07470177 — A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults · Phase 1 · not yet recruiting
- NCT07463053 — Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers · Phase 1 · not yet recruiting
- NCT07242274 — Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07565441 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jemincare
- Last refreshed: recently
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07565441.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing